WEX is developing a new class of non-opioid analgesics. WEX's lead product, Halneuron®, is a highly selective sodium channel blocker being developed to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain..
Relevance: 10.842886